No evidence for allelic association between schizophrenia and a functional variant of the human dopamine β-hydroxylase gene (DBH)

被引:0
作者
Williams, HJ [1 ]
Bray, N [1 ]
Murphy, KC [1 ]
Cardno, AG [1 ]
Jones, LA [1 ]
Owen, MJ [1 ]
机构
[1] Univ Wales Coll Med, Neuropsychiat Genet Dept, Cardiff CF4 4XN, S Glam, Wales
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 1999年 / 88卷 / 05期
基金
英国医学研究理事会;
关键词
schizophrenia; genetic polymorphism; catecholamine; RFLP;
D O I
10.1002/(SICI)1096-8628(19991015)88:5<557::AID-AJMG22>3.0.CO;2-F
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Dopamine P-hydroxylase (DBH), the enzyme that converts dopamine to norepinepherine, has been proposed as being involved in the aetiology of schizophrenia. Previous work identified a functional polymorphism at nucleotide 910 of the DBH gene that results in a codon change in the mature protein Ala304Ser, with the mutant allele being associated with a lower enzymatic activity. In this study we performed an RFLP analysis in an association study consisting of 178 unrelated schizophrenic patients and 178 unrelated control subjects, matched for age, sex, and ethnicity. The frequency of the Ser304 DBH allele was 0.10 in the patient group and 0.08 in the control group, with no significant allelic or genotypic association observed. Therefore, we were unable to obtain evidence that this polymorphism contributes directly to susceptibility to schizophrenia. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:557 / 559
页数:3
相关论文
共 22 条
  • [1] REDUCED SERUM DOPAMINE-BETA-HYDROXYLASE ACTIVITY IN PARANOID SCHIZOPHRENICS
    ARATO, M
    BAGDY, G
    BLUMEL, F
    PERENYI, A
    RIHMER, Z
    [J]. PHARMACOPSYCHIATRIA, 1983, 16 (01): : 19 - 22
  • [2] Cubells JF, 1997, AM J MED GENET, V74, P374, DOI 10.1002/(SICI)1096-8628(19970725)74:4<374::AID-AJMG7>3.0.CO
  • [3] 2-P
  • [4] Dopamine β-hydroxylase:: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation
    Cubells, JF
    van Kammen, DP
    Kelley, ME
    Anderson, GM
    O'Connor, DT
    Price, LH
    Malison, R
    Rao, PA
    Kobayashi, K
    Nagatsu, T
    Gelernter, J
    [J]. HUMAN GENETICS, 1998, 102 (05) : 533 - 540
  • [5] DeLisi L E, 1980, Biol Psychiatry, V15, P895
  • [6] FUGITA K, 1978, J NEUROCHEM, V30, P1569
  • [7] SERUM DOPAMINE BETA-HYDROXYLASE ACTIVITY AND TARDIVE-DYSKINESIA
    GLAZER, WM
    MORGENSTERN, H
    JESTE, DV
    ZAHNER, G
    HAFEZ, HM
    BENARROCHE, CL
    [J]. PSYCHONEUROENDOCRINOLOGY, 1987, 12 (04) : 289 - 294
  • [8] EXPRESSION OF 2 FORMS OF HUMAN DOPAMINE-BETA-HYDROXYLASE IN COS CELLS
    ISHII, A
    KOBAYASHI, K
    KIUCHI, K
    NAGATSU, T
    [J]. NEUROSCIENCE LETTERS, 1991, 125 (01) : 25 - 28
  • [9] A turning point in schizophrenia genetics
    Karayiorgou, M
    Gogos, JA
    [J]. NEURON, 1997, 19 (05) : 967 - 979
  • [10] HUMAN DOPAMINE BETA-HYDROXYLASE GENE - 2 MESSENGER-RNA TYPES HAVING DIFFERENT 3'-TERMINAL REGIONS ARE PRODUCED THROUGH ALTERNATIVE POLYADENYLATION
    KOBAYASHI, K
    KUROSAWA, Y
    FUJITA, K
    NAGATSU, T
    [J]. NUCLEIC ACIDS RESEARCH, 1989, 17 (03) : 1089 - 1102